IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 218 filers reported holding IMMUNOGEN INC in Q1 2022. The put-call ratio across all filers is 0.24 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $284,867 | -15.9% | 17,950 | 0.0% | 0.07% | -18.1% |
| Q2 2023 | $338,717 | +391.4% | 17,950 | 0.0% | 0.08% | +361.1% |
| Q1 2023 | $68,928 | -22.6% | 17,950 | 0.0% | 0.02% | -30.8% |
| Q4 2022 | $89,032 | +3.5% | 17,950 | 0.0% | 0.03% | -3.7% |
| Q3 2022 | $86,000 | +6.2% | 17,950 | 0.0% | 0.03% | +12.5% |
| Q2 2022 | $81,000 | -4.7% | 17,950 | 0.0% | 0.02% | 0.0% |
| Q1 2022 | $85,000 | -24.8% | 17,950 | +18.1% | 0.02% | -29.4% |
| Q4 2021 | $113,000 | +31.4% | 15,200 | 0.0% | 0.03% | +17.2% |
| Q3 2021 | $86,000 | -14.0% | 15,200 | 0.0% | 0.03% | -14.7% |
| Q2 2021 | $100,000 | -18.7% | 15,200 | 0.0% | 0.03% | -30.6% |
| Q1 2021 | $123,000 | +25.5% | 15,200 | 0.0% | 0.05% | +19.5% |
| Q4 2020 | $98,000 | +78.2% | 15,200 | 0.0% | 0.04% | +51.9% |
| Q3 2020 | $55,000 | – | 15,200 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 17,503,417 | $277,779,228 | 13.22% |
| Fairmount Funds Management LLC | 5,929,592 | $94,102,625 | 11.32% |
| CM Management, LLC | 500,000 | $7,935,000 | 8.42% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 1,307,435 | $20,748,993 | 6.29% |
| Altium Capital Management LP | 725,000 | $11,505,750 | 6.00% |
| RA Capital Management | 13,322,288 | $211,424,711 | 4.16% |
| TANG CAPITAL MANAGEMENT LLC | 1,500,000 | $23,805,000 | 3.36% |
| BRIDGER MANAGEMENT, LLC | 467,220 | $7,414,781 | 2.73% |
| Birchview Capital, LP | 190,000 | $3,015,300 | 2.57% |
| Boxer Capital, LLC | 2,961,000 | $46,991,070 | 2.50% |